UNSPSC 51142508: Pramipexole

This classification denotes an antidepressant agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 83619PEU5T. European Medicines Agency schedules Pramipexole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09990MIG. Pramipexole generally arises in the molecular formula C10H17N3S.

UNSPSC 51142508 Pramipexole is a Commodity code that nominally covers a specific pharmaceutical product, but the recent state and local procurement activity under this code shows a significant scope mismatch — Seminole County, Florida's IFB60459723LAS solicitation (posted June 30, 2026, due July 26, 2023) seeks naloxone and safe drug deactivation systems for community health support, products unrelated to pramipexole's therapeutic class. The code shows minimal recent state and local activity, and what does appear tagged to it does not align with the code's stated pharmaceutical scope. State and local procurement offices appear to use this code inconsistently or incorrectly for opioid-response and harm-reduction equipment procurement rather than for pramipexole itself.

The Seminole County opportunity represents the only recent record available under this code in the dataset. Seminole County Community Health requested 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries to its facility at 520 W. Lake Mary Blvd, Sanford, Florida, under a two-year initial term with an optional one-year renewal. The IFB required electronic bid submission through Seminole County's e-Procurement Portal, with unit-cost line items, drug-free workplace certification, E-Verify compliance, and standard insurance coverage (workers' compensation, commercial general liability, professional liability). The contract included potential FEMA funding, introducing federal compliance requirements. Given the code's poor alignment with recent solicitations and the absence of additional pramipexole-specific opportunities in the dataset, this code presents limited procurement visibility for vendors seeking state and local health-sector pharmaceutical contracts.